Search Results
Mar 23, 2026, 17:00 ET Salus Scientific Appoints Medical Device Executive Will Martin to Board of Directors
efforts and successfully guided the company through multiple financings and a strategic acquisition by ClearPoint Neuro in 2025."Will brings a rare combination of operational excellence, strategic vision, and proven execution across the full lifecycle of medical device companies," said Todd O. Flohr,
More news about: Salus Scientific
Mar 23, 2026, 15:57 ET Luxury developer, Aristo, invites global buyers seeking stability to consider The Bahamas as geopolitical uncertainty rises
red tape," he said. "For those looking for a place that combines safety, financial advantages, natural beauty, and luxury living, The Bahamas offers a rare combination — and Aqualina represents one of the finest ways to experience it."Media Contact: Stephen Hunt242-376-2177
More news about: Aristo
Mar 23, 2026, 14:14 ET Utah's Forgotten Uranium Belt Is Getting a Second Look. Here's Why the Timing Matters.
less than conventional mining.On the rare earth side, MP Materials (NYSE: MP) operates the only scaled rare earth mining and processing site in North America at Mountain Pass, California. As Beijing tightened export controls on seven strategic rare earth elements in early 2026, MP's position as
More news about: Equity Insider
Mar 23, 2026, 14:10 ET A New Commitment to Advanced Surgical Training Honors Robert A. Altman
superheroes."Carter, who broke ground in television with her iconic portrayal of Wonder Woman, established the Foundation after Altman sadly died from a rare blood cancer—secondary myeloid leukemia—in 2021.
More news about: MedStar Health
Mar 23, 2026, 13:33 ET PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™
help improve their treatment experiences."About PANTHERx RarePANTHERx Rare makes rare disease care more hyper-personalized and less overwhelming by focusing relentlessly on each patient and each therapy. PANTHERx experts develop deep personal relationships with patients, prescribers,
More news about: PANTHERx Rare Pharmacy
Mar 23, 2026, 13:18 ET Designed for Impossible: I.S.T Showcases Space-Proven Polyimide Technologies at SATShow Week 2026
developed using the company's proprietary polyimide synthesis technology. Designed to withstand the harsh conditions of space, TORMED® offers a rare combination of:High optical transparencyRadiation and UV resistanceUltra-low outgassingLow dielectric
More news about: I.S.T CORPORATION
Mar 23, 2026, 12:14 ET Shianne Sampson Joins JumpCloud as CRO to Drive Global Growth Strategy
Security Officer. Both roles strengthen JumpCloud's leadership as the company grows quickly in enterprise and global markets."Shianne is a rare leader who combines deep operational rigor with a profound commitment to people and leadership development," said Rajat Bhargava, CEO, JumpCloud. "As
More news about: JumpCloud, Inc.
Mar 23, 2026, 12:00 ET MGM Collection with Marriott Bonvoy Unveils 'Best of Both Worlds' Moments Series
Collection Resort & Casino, Las Vegas with a two-night suite stay, dinner at CARBONE RIVIERA, brunch in the Conservatory Garden and rare access to the iconic Bellagio Fountains aboard the Fortuna boat. The experience continues in Italy with a three-night suite stay in Lake Como, complete
More news about: Marriott International, Inc.
Mar 23, 2026, 10:45 ET Highly acclaimed Remus Bourbon introduces the Remus Bottle Club
A treat for aficionados and collectors, the new club delivers rare and award-winning Remus Bourbon expressions to members' doorstepsST. LOUIS, March 23, 2026 /PRNewswire/ -- Remus Bourbon has the
More news about: Remus Bourbon
Mar 23, 2026, 10:16 ET Refurbished and Used Mobile Phones Market to Reach US$ 135.4 Billion by 2033 Expands Amid Circular Economy and Affordable Smartphone Demand - Persistence Market Research
environmental awareness is another key driver of the refurbished and used mobile phones market. Smartphone production requires significant resources such as rare metals, energy, and water. Extending the lifecycle of existing devices through refurbishment helps reduce electronic waste and lowers the environmental
More news about: Persistence Market Research Pvt. Ltd.
Mar 23, 2026, 10:00 ET DealerCX Builds Its C-Suite with Automotive Industry Veterans
the same discipline — focused as much on developing the people around him as on the numbers they produce."Jack and Gary have built something rare — a company with a strong foundation, a clear mission, and a genuine commitment to helping dealers succeed," said Scott. "I look forward to building
More news about: DealerCX
Mar 23, 2026, 09:06 ET PLT Launches New Ingredient To Improve Joint Structure, Strength and Function, Promoting Long-Term Mobility
saw significant improvements in multiple measures of joint structure alongside functional outcomes, supported by advanced imaging. That combination is rare in our category, and it opens the door for our customers to develop new products that may contribute to long-term mobility across different life stages.
More news about: PLT Health Solutions
Mar 23, 2026, 09:00 ET Orsini to Serve as Single-Source Specialty Pharmacy Partner for Glaukos' Epioxa™
care since 1987, Orsini is a leader in rare diseases and gene therapies. Orsini partners with biopharma innovators, healthcare providers and payors to support patients and their families in accessing revolutionary treatments for rare diseases. Through integrated rare disease pharmacy solutions including
More news about: Orsini
Mar 23, 2026, 09:00 ET PASSIONFLIX OPTIONS K-POP ROMANCE NOVEL "MY SUMMER IN SEOUL" BY RACHEL VAN DYKEN
could jeopardize everything.With K-pop continuing to dominate global music, fashion, and digital culture, My Summer in Seoul offers a rare, intimate look inside the industry, blending the glamour fans love with the emotional stakes and forbidden tension they cannot get enough of."We're
More news about: PASSIONFLIX
Mar 23, 2026, 09:00 ET Luxury Group by Marriott International Unveils "Art of Arrival," Bringing Artistic Perspective to Iconic Hotel Spaces in Greater China
created during the residency.For Chen Zuo, the residency represented a fundamental recalibration of creative rhythm. "It granted me the rare gift of unhurried focus – time to observe, reflect, and evolve my practice within a complex cultural framework," said Chen Zuo. "When the residency
More news about: Marriott International, Inc.
Mar 23, 2026, 08:34 ET AlarMax Appoints Mark Benedetti as Chief Financial Officer to Support Continued Growth and Strategic Expansion
President Scott Shelander and the executive leadership team to align financial strategy with AlarMax's continued national expansion."Mark brings a rare combination of financial rigor, operational insight, and leadership experience," said Scott Shelander, President of AlarMax. "He understands how to
More news about: AlarMax Distributors Inc.
Mar 23, 2026, 08:30 ET The Glomerular Revolution: Understanding the New Wave of Breakthroughs in Rare Kidney Diseases, Upcoming Webinar Hosted by Xtalks
free webinar, learn how biomarker-informed strategies and trial execution choices can improve decision-making in rare kidney disease. The featured speakers will provide an overview of rare renal diseases, including IgAN, C3G, FSGS and PMN, and discuss how newer treatments are changing care. Attendees
More news about: Xtalks
Mar 23, 2026, 08:30 ET Improve Recruitment Outcomes Through More Diverse Clinical Trials, Upcoming Webinar Hosted by Xtalks
about numbers, but also about trust, access and designing studies that work for people in practice, not just theory. This is particularly true in the rare disease research space, where barriers to participation are often amplified, resources are slimmer and traditional patient recruitment approaches often
More news about: Xtalks
Mar 23, 2026, 08:00 ET Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa
diagnose, or treat a rare disease or condition. Orphan drug designation qualifies sponsors for incentives including tax credits for qualified clinical trials, exemption from user fees, and the potential for seven years of market exclusivity after approval.2RP is a rare progressive blinding
More news about: Sumitomo Pharma America
Mar 23, 2026, 07:30 ET EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
Development (NICHD) and has been recognized as an NIH SBIR Success Story. In 2025, ENDO-205 received an NIH Commercialization Readiness Pilot grant with a rare "unicorn" perfect overall impact score of 10, reflecting the highest level of scientific innovation, research rigor, and commercial viability. EndoCyclic
More news about: EndoCyclic Therapeutics
Mar 23, 2026, 07:30 ET HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that findings from recent supportive trials with HyBryte™ (synthetic hypericin) in the
More news about: Soligenix
Mar 23, 2026, 07:24 ET Interna Therapeutics Announces Human Challenge Trial Agreement with the University of Oxford to Advance Intranasal MNM-siRNA SARS-CoV-2 Prophylaxis Program
and peptides – into cells and tissues that have historically been difficult to access. Interna is advancing programs in respiratory viral infections, rare diseases, and oncology.
More news about: Interna Therapeutics
Mar 23, 2026, 07:00 ET Summit Explore Signs Term Sheet with Power Minerals to Develop Multi-Salar Lithium Project in Argentina
mining leases covering 147 square kilometres in Salta Province, Argentina, within the Lithium Triangle. Power Minerals also holds the Santa Anna niobium-rare earth-gallium project in Goiás State, Brazil, and exploration assets in South Australia. The company was incorporated in 2002 and is headquartered in
More news about: Summit Explore Corporation
Mar 23, 2026, 07:00 ET BioLineRx Reports 2025 Financial Results and Provides Corporate Update
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2025, and provided a corporate update.
More news about: BioLineRx Ltd.
Mar 23, 2026, 07:00 ET Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
6 and durable culture conversion at Month 15.About MAC Lung DiseaseMycobacterium avium complex (MAC) lung disease is a rare and serious disease that can significantly increase morbidity and mortality. Patients with MAC lung disease can experience a range of symptoms that
More news about: Insmed Incorporated